143 related articles for article (PubMed ID: 3929517)
21. Postoperative evaluation of dopaminergic tone in prolactinoma patients. II. Plasma thyrotropin response to metoclopramide.
De Marinis L; Mancini A; Maira G; Anile C; Menini E; Barbarino A
J Clin Endocrinol Metab; 1984 Mar; 58(3):405-9. PubMed ID: 6693543
[TBL] [Abstract][Full Text] [Related]
22. Prolactin-secreting pituitary adenoma in a man with gigantism: a case report.
Peillon F; Philippon J; Brandi AM; Fohanno D; Laplane D; Dubois MP; Decourt J
Acta Endocrinol (Copenh); 1979 Dec; 92(4):627-39. PubMed ID: 394552
[TBL] [Abstract][Full Text] [Related]
23. Long-term bromocriptine therapy may restore the inhibitory control of prolactin release in some patients with pathological hyperprolactinemia.
Ho KY; Smythe GA; Compton PJ; Lazarus L
Aust N Z J Med; 1985 Apr; 15(2):213-9. PubMed ID: 3927887
[TBL] [Abstract][Full Text] [Related]
24. Altered responsiveness to hypophysiotrophic hormones of perifused rat pituitary tumours.
Carlson HE; Mariz IK; Briggs JE; Daughaday WH
Acta Endocrinol (Copenh); 1977 Mar; 84(3):512-22. PubMed ID: 190840
[TBL] [Abstract][Full Text] [Related]
25. Correlation between the number of thyroliberin binding sites, the tumour size and the plasma prolactin level in human prolactin-secreting adenomas.
Le Dafniet M; Pagesy P; Brandi AM; Racadot J; Peillon F
Acta Endocrinol (Copenh); 1985 Apr; 108(4):464-7. PubMed ID: 2986400
[TBL] [Abstract][Full Text] [Related]
26. Changes in pituitary hormones during and following transsphenoidal removal of prolactinomas.
Casper RF; Rakoff JS; Quigley ME; Gilliland B; Alksne J; Yen SS
Am J Obstet Gynecol; 1980 Feb; 136(4):518-23. PubMed ID: 6766667
[TBL] [Abstract][Full Text] [Related]
27. Pituitary autonomy in hyperprolactinemic secondary amenorrhea: results of hypothalamic-pituitary testing.
Healy DL; Pepperell RJ; Stockdale J; Bremner WJ; Burger HG
J Clin Endocrinol Metab; 1977 May; 44(5):809-19. PubMed ID: 404308
[TBL] [Abstract][Full Text] [Related]
28. The preoperative and postoperative investigation of TSH and prolactin release in the management of patients with hyperprolactinaemia due to prolactinomas and nonfunctional pituitary tumours: relationship to adenoma size at surgery.
Scanlon MF; Peters JR; Salvador J; Richards SH; John R; Howell S; Williams ED; Thomas JP; Hall R
Clin Endocrinol (Oxf); 1986 Apr; 24(4):435-46. PubMed ID: 3091297
[TBL] [Abstract][Full Text] [Related]
29. Pituitary microadenoma: diagnostic studies.
Pineda G; Valdes M; Castro M; Stevenson C
Clin Endocrinol (Oxf); 1979 Jun; 10(6):583-94. PubMed ID: 113146
[TBL] [Abstract][Full Text] [Related]
30. Prolactin and growth hormone responses to dermorphin in patients with prolactin-secreting pituitary adenoma.
degli Uberti EC; Trasforini G; Salvadori S; Margutti A; Rotola C; Bianconi M; Teodori V; Tomatis R; Pansini R
Metabolism; 1985 Sep; 34(9):874-9. PubMed ID: 4033428
[TBL] [Abstract][Full Text] [Related]
31. The use of thyrotropin-releasing hormone in distinguishing prolactin-secreting pituitary adenoma.
Marrs RP; Bertolli SJ; Kletzky OA
Am J Obstet Gynecol; 1980 Nov; 138(6):620-5. PubMed ID: 6776812
[TBL] [Abstract][Full Text] [Related]
32. Thyrotropin and prolactin in patients with hypothalamus-pituitary diseases.
Valenti G; Vescovi PP; Banchini A; Chiodera P; Volpi R; Ceda GP; Tarditi E
Ric Clin Lab; 1978; 8(3):179-82. PubMed ID: 106450
[TBL] [Abstract][Full Text] [Related]
33. Benserazide and nomifensine in the diagnosis of prolactin-secreting pituitary adenomas.
Pontiroli AE; Loda G; Roggia A; Scagliola P; Falsetti L
Acta Endocrinol (Copenh); 1982 Oct; 101(2):171-9. PubMed ID: 7136447
[TBL] [Abstract][Full Text] [Related]
34. The value of the thyrotropin-releasing hormone test in patients with prolactin-secreting pituitary tumors and suprasellar non-pituitary tumors.
Klijn JG; Lamberts SW; de Jong FH; Birkenhäger JC
Fertil Steril; 1981 Feb; 35(2):155-61. PubMed ID: 6781936
[TBL] [Abstract][Full Text] [Related]
35. Hyperthyroidism caused by a pituitary thyrotrophin-secreting tumour with excessive secretion of thyrotrophin-releasing hormone and subsequently followed by Graves' disease in a middle-aged woman.
Kamoi K; Mitsuma T; Sato H; Yokoyama M; Washiyama K; Tanaka R; Arai O; Takasu N; Yamada T
Acta Endocrinol (Copenh); 1985 Nov; 110(3):373-82. PubMed ID: 3934894
[TBL] [Abstract][Full Text] [Related]
36. Serum gonadotrophin pulsatile secretion in men with Prl-secreting and non-secreting pituitary tumours.
Ambrosi B; Giovine C; Nava C; Elli R; Faglia G
Acta Endocrinol (Copenh); 1985 May; 109(1):1-6. PubMed ID: 3923752
[TBL] [Abstract][Full Text] [Related]
37. [The properties of prolactin secretion in patients with prolactin secreting pituitary adenomas].
Sato S
Nihon Naibunpi Gakkai Zasshi; 1987 Aug; 63(8):947-60. PubMed ID: 3123284
[TBL] [Abstract][Full Text] [Related]
38. The response to TRH, LH-RH, metyrapone and vasopressin in patients with hypothalamo-pituitary disorders.
Lundberg PO; Wide L
Eur J Clin Invest; 1973 Jan; 3(1):49-56. PubMed ID: 4347096
[No Abstract] [Full Text] [Related]
39. Thyrotropin releasing hormone does not stimulate prolactin release in the preterm human fetus.
Roti E; Gardini E; Minelli R; Bianconi L; Alboni A; Braverman LE
Acta Endocrinol (Copenh); 1990 Apr; 122(4):462-6. PubMed ID: 2110411
[TBL] [Abstract][Full Text] [Related]
40. The inability of dynamic tests of prolactin and TSH secretion to differentiate between tumorous and non-tumorous hyperprolactinemia.
Prescott RW; Johnston DG; Taylor PK; Haigh J; Weightman DR; Hall K; Cook DB
J Endocrinol Invest; 1985 Feb; 8(1):49-54. PubMed ID: 3921596
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
